• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硼通过改变氧化应激和凋亡途径减轻二乙基亚硝胺诱导的C3H/HeN小鼠肝细胞癌。

Boron attenuated diethylnitrosamine induced hepatocellular carcinoma in C3H/HeN mice via alteration of oxidative stress and apoptotic pathway.

作者信息

Wei Ying, Yi Jin-Ke, Chen Jun, Huang Huimin, Wu Lun, Yin Xufeng, Wang Jinjin

机构信息

Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei 442008, China.

Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Rehabilitation department, Shiyan, Hubei 442008, China.

出版信息

J Trace Elem Med Biol. 2022 Dec;74:127052. doi: 10.1016/j.jtemb.2022.127052. Epub 2022 Aug 3.

DOI:10.1016/j.jtemb.2022.127052
PMID:35952449
Abstract

BACKGROUND

Reactive oxygen species (ROS) regulate various cellular signaling pathways and play an important role in the occurrence and development of hepatocellular carcinoma (HCC). Excessive accumulation of ROS can promote HCC. Trace element boron has a wide range of biological effects, including anti-oxidation, anti-tumor, immune regulation and so on.

METHODS

In this study, we investigated the anticancer effects of Sodium tetraborate decahydrate (NaB) in improving oxidative stress and regulating apoptosis in mouse HCC. HCC was induced by intraperitoneal injection of diethylnitrosamine (DEN) 25 mg/kg once at the age of 2 weeks and 100 mg/kg again at the age of 6 weeks in healthy C3H/HeN male mice. At 8 weeks of age, different concentrations of NaB were given intragastric treatment once a day for 20 weeks. Oxidative stress markers, antioxidant status and liver enzyme analysis were detected to evaluate the effectiveness of NaB in inhibiting cancer induction. The anticancer properties of NaB were confirmed by observing the liver index and morphology, and analyzing the expression of apoptotic genes and proteins. Our results showed that boron significantly reduced the production of ROS, and down-regulated the expression of the anti-apoptotic protein Bcl2 and up-regulated the expression of the pro-apoptotic proteins P53, Bax, and caspase 3.

CONCLUSION

Boron has great potential to reduce the effects of oxidative stress, which may help it inhibit the progression of HCC.

摘要

背景

活性氧(ROS)调节多种细胞信号通路,在肝细胞癌(HCC)的发生发展中起重要作用。ROS的过度积累可促进肝癌发生。微量元素硼具有广泛的生物学效应,包括抗氧化、抗肿瘤、免疫调节等。

方法

在本研究中,我们研究了十水合四硼酸钠(NaB)在改善小鼠肝癌氧化应激和调节细胞凋亡方面的抗癌作用。通过在2周龄时腹腔注射25mg/kg二乙基亚硝胺(DEN)一次,6周龄时再次注射100mg/kg,诱导健康C3H/HeN雄性小鼠发生肝癌。8周龄时,给予不同浓度的NaB灌胃治疗,每天一次,共20周。检测氧化应激标志物、抗氧化状态和肝酶分析,以评估NaB抑制癌症诱导的有效性。通过观察肝脏指数和形态,并分析凋亡基因和蛋白质的表达,证实了NaB的抗癌特性。我们的结果表明,硼显著降低了ROS的产生,下调了抗凋亡蛋白Bcl2的表达,上调了促凋亡蛋白P53、Bax和caspase 3的表达。

结论

硼具有极大潜力减轻氧化应激的影响,这可能有助于其抑制肝癌进展。

相似文献

1
Boron attenuated diethylnitrosamine induced hepatocellular carcinoma in C3H/HeN mice via alteration of oxidative stress and apoptotic pathway.硼通过改变氧化应激和凋亡途径减轻二乙基亚硝胺诱导的C3H/HeN小鼠肝细胞癌。
J Trace Elem Med Biol. 2022 Dec;74:127052. doi: 10.1016/j.jtemb.2022.127052. Epub 2022 Aug 3.
2
The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways.β-紫罗兰酮和/或索拉非尼通过其抗氧化作用、PPAR-γ、FOXO-1、Ki-67、Bax 和 Bcl-2 信号通路对肝癌的潜在化疗作用。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Sep;393(9):1611-1624. doi: 10.1007/s00210-020-01863-9. Epub 2020 Apr 8.
3
Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.白藜芦醇在雄性 Wistar 大鼠早期和晚期阶段干扰 N-亚硝基二乙胺诱导的肝癌。
Mol Med Rep. 2011 Nov-Dec;4(6):1211-7. doi: 10.3892/mmr.2011.555. Epub 2011 Aug 16.
4
Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.藜芦醇对二乙基亚硝胺诱导的大鼠肝癌的保护作用及其机制。
Eur J Pharmacol. 2016 Aug 5;784:173-80. doi: 10.1016/j.ejphar.2016.04.045. Epub 2016 May 12.
5
Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IkBα.表松脂烷-11α-羟基-15-氧代-贝壳杉-16-烯-19-酸通过稳定 IkBα 抑制肝癌的体内外活性。
Invest New Drugs. 2012 Dec;30(6):2210-8. doi: 10.1007/s10637-011-9791-5. Epub 2012 Jan 7.
6
Hepatoprotective effect of boldine against diethylnitrosamine-induced hepatocarcinogenesis in wistar rats.壮丁酸对二乙基亚硝胺诱导的 Wistar 大鼠肝癌形成的保护作用。
J Biochem Mol Toxicol. 2019 Dec;33(12):e22404. doi: 10.1002/jbt.22404. Epub 2019 Oct 8.
7
The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.ADAM8在二乙基亚硝胺诱导的小鼠肝细胞癌进展中的重要作用。
Hum Exp Toxicol. 2015 Nov;34(11):1053-72. doi: 10.1177/0960327114567767. Epub 2015 Jan 13.
8
Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.薯蓣皂苷通过诱导细胞凋亡以及调节TP53、BAX、BCL2和裂解的CASP3来抑制肝细胞癌肿瘤生长。
Phytomedicine. 2016 Nov 15;23(12):1329-1336. doi: 10.1016/j.phymed.2016.07.003. Epub 2016 Jul 5.
9
Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.三萜类化合物千里光苦味醇通过下调 NF-κB 通路的氧化应激、炎症和病理学,减弱了二乙基亚硝胺诱导的肝癌。
Inflammopharmacology. 2018 Feb;26(1):133-146. doi: 10.1007/s10787-017-0350-3. Epub 2017 Jun 12.
10
Potential anticancer effects of cyclo(-Pro-Tyr) against N-diethyl nitrosamine induced hepatocellular carcinoma in mouse through PI3K/AKT signaling.环(脯氨酰-酪氨酰)通过 PI3K/AKT 信号通路对二乙基亚硝胺诱导的小鼠肝癌的潜在抗癌作用。
Environ Toxicol. 2022 Feb;37(2):256-269. doi: 10.1002/tox.23395. Epub 2021 Nov 2.

引用本文的文献

1
Streptomyces Bioactive Metabolites Prevent Liver Cancer through Apoptosis, Inhibiting Oxidative Stress and Inflammatory Markers in Diethylnitrosamine-Induced Hepatocellular Carcinoma.链霉菌生物活性代谢产物通过诱导细胞凋亡、抑制氧化应激以及二乙基亚硝胺诱导的肝细胞癌中的炎症标志物来预防肝癌。
Biomedicines. 2023 Mar 29;11(4):1054. doi: 10.3390/biomedicines11041054.